ARCHIVES

Investigator Loses Contract Because He Had A New Idea; Virus Working Group Incensed By Unfairness

This article is from The Cancer Letter archive.

Vol. 01 No. 03 | February 22, 1974

Download PDF Visit The Full Archive

Related Articles

Phase III Study Evaluating Halaven Fails To Meet Primary Endpoints

July 27, 2012

Secondary AML In High-Dose Chemo Trial Cause For Careful Monitoring, NCI Says

August 19, 1994

Farber Grant Probe Misses Real Story

July 8, 1977

Funding opportunities listed.

April 16, 2004

Eppley Probe Could Lead to Tighter Reporting By NIH supported Investigators

June 17, 1977

Rituximab Prolonged Survival Of CLL In Phase III Study

September 24, 2010